Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F8Y6M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,166
Award facts
- Contract value 100% obligated
- $10,165.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,165.67 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on December 2, 2025, with completion scheduled for December 3, 2025. This competitive delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate office location in the same city. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems.
The Jardiance delivery is consistent with AmerisourceBergen's established role as a primary vendor for federal military and veteran healthcare systems, supplying a diverse portfolio of pharmaceutical products across multiple therapeutic domains. As a major healthcare solutions provider in the federal contracting space, AmerisourceBergen fulfills the Defense Health Agency's pharmaceutical needs through its comprehensive DLA contract vehicle, which enables efficient procurement of both brand-name and generic medications to support military personnel and veteran beneficiaries. The company's competitive award history and extensive contract portfolio demonstrate its capability to meet federal procurement standards and deliver critical medical commodities on established timelines.
Quick answers
Who was awarded contract SPE2DR26F8Y6M?
SPE2DR26F8Y6M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F8Y6M worth?
The government has obligated $10,166 on SPE2DR26F8Y6M.
Is contract SPE2DR26F8Y6M an order under another contract?
Yes. SPE2DR26F8Y6M is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y6M competed?
The extent of competition for SPE2DR26F8Y6M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award